Frontiers in Oncology (Mar 2023)
Corrigendum: Human Wharton’s Jelly stem cell (hWJSC) extracts inhibit ovarian cancer cell lines OVCAR3 and SKOV3 in vitro by inducing cell cycle arrest and apoptosis
- Gauthaman Kalamegam,
- Gauthaman Kalamegam,
- Khalid Hussein Wali Sait,
- Farid Ahmed,
- Roaa Kadam,
- Peter Natesan Pushparaj,
- Nisreen Anfinan,
- Mahmood Rasool,
- Mohammad Sarwar Jamal,
- Muhammed Abu-Elmagd,
- Mohammed Al-Qahtani
Affiliations
- Gauthaman Kalamegam
- Center of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah, Saudi Arabia
- Gauthaman Kalamegam
- Faculty of Medicine, Asian Institute of Medicine, Science and Technology (AIMST) University, Bedong, Malaysia
- Khalid Hussein Wali Sait
- Department of Obstetrics and Gynaecology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia
- Farid Ahmed
- Center of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah, Saudi Arabia
- Roaa Kadam
- Center of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah, Saudi Arabia
- Peter Natesan Pushparaj
- Center of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah, Saudi Arabia
- Nisreen Anfinan
- Department of Obstetrics and Gynaecology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia
- Mahmood Rasool
- Center of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah, Saudi Arabia
- Mohammad Sarwar Jamal
- King Fahad Medical Research Centre (KFMRC), King Abdulaziz University, Jeddah, Saudi Arabia
- Muhammed Abu-Elmagd
- Center of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah, Saudi Arabia
- Mohammed Al-Qahtani
- Center of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah, Saudi Arabia
- DOI
- https://doi.org/10.3389/fonc.2023.1171430
- Journal volume & issue
-
Vol. 13
Abstract
No abstracts available.Keywords